Navigation Links
MedQuist Evaluating Whether a Sale of the Company is in the Best Interests of the Company and its Shareholders
Date:11/2/2007

MT. LAUREL, N.J., Nov. 2 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) announces that its Board of Directors, in connection with its previously-disclosed review of strategic alternatives for the Company, is evaluating whether a sale of the Company is in the best interests of the Company and its shareholders, in light of the announcement earlier today by Koninklijke Philips Electronics N.V. ("Philips") of its decision to proceed with the sale of its 70% ownership interest in the Company if a satisfactory price and other acceptable terms can be realized. There is no assurance that any sale transaction will occur as a result of the evaluation.

About MedQuist:

MedQuist is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web- based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties, including without limitation that the Company's evaluation of whether a sale of the Company is in the best interest of the Company and its shareholders may not result in a sale of the Company, and that any potential sale transaction reviewed by the Company may not be attractive to shareholders and may not result in enhanced shareholder value. Actual outcomes and results may differ materially from what is expressed or forecasted in forward- looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Evaluating The Risks and Benefits of Hormone Therapy
2. Evaluating The Risk Factors Of Osteoporosis
3. Evaluating The Benefits Of A Low – carb Diet
4. US Doctors re-evaluating Conjoined Twin Surgery
5. VA Should Revise Its Methods for Evaluating PTSD in Ex-military Personnel
6. Experts Question Whether Expert Patient Programmes Cut Healthcare Use
7. US Court Asked to Decide Whether Childhood Vaccines can Cause Autism
8. Researchers To Test Whether ADHD Medication Helps Young Adults While Driving
9. Medicis Pharmaceutical company enters pediatric market
10. Problems Of a Growing Company
11. Teenagers Take More Risk-Taking Behaviors In The Company Of Same Sex Friends
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... , ... Kevin Harrington (one of the original Sharks from mega-hit reality series ... topic of Beauty and Personal Care. , Everyone makes New Year’s ... commit to these changes than beginning with personal care and beauty products? AsSeenOnTV.pro will ...
(Date:1/17/2017)... TX (PRWEB) , ... January 17, 2017 , ... Mirror ... have earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. Practice ... named part of this elite group of providers. , Produced by Zeltiq, CoolSculpting ...
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, ... the fourth Cradle to Cradle Product Design Challenge , the Cradle to ... series of six circular design challenges scheduled to run through early 2018. The challenges ...
(Date:1/17/2017)... ... ... SC&H Group, a leading audit, tax, and consulting firm, announced that Chris ... practice . Rossi is the third technology consulting leader to join SC&H Group’s IT ... the practice continues to expand.     , Bringing more than 25 years of business consulting ...
(Date:1/17/2017)... ... January 17, 2017 , ... The Sharie Withers Agency, a ... the latest beneficiary of their thriving community involvement program. The current campaign fundraises ... the dreams of terminally ill patients. Donations to this worthy cause may now ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... , Jan 17, 2017 Research and ... Devices System Market 2016-2020" report to their offering. ... The global artificial pancreas ... the period 2016-2020. Global Artificial Pancreas Devices System Market ... inputs from industry experts. The report covers the market landscape and ...
(Date:1/17/2017)... , Jan. 17, 2017 The interventional ... billion by 2021 from USD 6.35 billion in 2016, ... driving the growth of this market are rising incidence ... for minimally invasive surgeries. The global interventional ... application, and region. On the basis of type, the ...
(Date:1/17/2017)... 2017 Management to Discuss Acquisition of ... KIT-302 Development On Track For An NDA ... in Q1 2017   ... Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV ; TASE: KTOV), an innovative biopharmaceutical ... 23 rd at 8:30am Eastern Time to discuss the recent acquisition of ...
Breaking Medicine Technology: